생명과학회지 (Journal of Life Science)

  • 제20권11호
  • /
  • Pages.1683-1690
  • /
  • 2010
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

고콜레스테롤 식이를 섭취한 흰쥐에서 이소플라본 보충이 혈청 지질패턴 및 항산화체계에 미치는 영향

Effects of Isoflavone Supplementation on Lipid Profiles and Antioxidant Systems in Rats Fed with Cholesterol Diet

  • 김수연 (연세대학교 생활과학대학 식품영양과학연구소) ;
  • 김순영 (연세대학교 생활과학대학 식품영양학과) ;
  • 정은정 (강남대학교 교양학부) ;
  • 윤선 (연세대학교 생활과학대학 식품영양학과) ;
  • 박정화 (연세대학교 생활과학대학 식품영양과학연구소)
  • Kim, Soo-Yeon (Research Institute of Food and Nutritional Sciences, Yonsei University) ;
  • Kim, Soon-Young (Department of Food & Nutrition, Yonsei University) ;
  • Chung, Chung-Eun (Division of General Studies, Kangnam University) ;
  • Yoon, Sun (Department of Food & Nutrition, Yonsei University) ;
  • Park, Jung-Hwa (Research Institute of Food and Nutritional Sciences, Yonsei University)
  • 투고 : 2010.09.04
  • 심사 : 2010.09.10
  • 발행 : 2010.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

심혈관질환 및 암 등의 만성퇴행성 질환을 예방하는 식이성분 이소플라본에 대한 관심이 고조되고 있다. 그러나 대두 단백질에 포함된 성분으로서의 이소플라본의 효과에 관해서는 많은 검증이 되어왔지만 정제된 이소플라본 자체의 생리활성에 관해서는 아직 논란의 여지가 많이 있다. 특히 이소플라본의 지방감소 효과, 항산화작용등에 관해서는 질병 예방의 효과와 관련하여 규명되어야 할 부분이다. 본 연구에서는 이소플라본 첨가 식이가 고콜레스테롤 식이를 섭취하는 흰쥐와 일반식이를 섭취하는 흰쥐의 지질 패턴과 지질과산화 및 항산화 체계에 미치는 영향을 알아보고자 하였다. 생후 7주령 Sprague Dawley 수컷 흰쥐를 사용하여 대조군(basal diet, B), 이소플라본 보충군(B+Isoflavone, BI) 고콜레스테롤군(B+cholesterol, BC) 및 고콜레스테롤-이소플라본 보충군(BC+Isoflavone, BIC)으로 나누어 8주간 사육하였다. Two-way ANOVA를 실시하여 이소플라본과 콜레스테롤 보충효과 및 각 변수에 대한 두 요인간의 상호작용을 검증하였다 총 콜레스테롤, VLDL+LDL 콜레스테롤, atherogenic index는 콜레스테롤 비첨가 군 중에서(B, BI) 이소플라본에 의해 유의하게 낮았지는 효과가 있었고(각 각 p=0.0002, p<0.0001, p=0.0042). 콜레스테롤 첨가군(BC, BIC)들을 비교했을 때는 VLDL+LDL 농도만이 이소플라본 첨가시(BIC) 유의하게 낮았다(p<0.0001). T-SOD는 콜레스테롤 비첨가 군 중에서(B, BI) 이소플라본 첨가군(BI)이 비첨가군(B)보다 유의하게 높았고(각 각 p=0.0317) TAS는 콜레스테롤 첨가 여부와 관계 없이 이소플라본 첨가군(BI, BIC)이 비첨가군(B, BC)보다 유의하게 높게 나타났다(p<0.0001). 혈청 지질과산화, 총 항산화능, 항산화 효소활성에 영향을 미치는 이소플라본과 콜레스테롤의 모든 효과는 각 각 독립적인 것으로 나타났다. 이소플라본이 혈청 지질패턴을 개선하고 항산화능을 증가시킴으로써 심혈관계질환을 비롯한 만성퇴행성 질환을 예방해 줄 수 있을 것으로 사료되며 이소플라본의 식이 첨가량에 따른 효과에 대해 보다 심층적인 연구가 지속되어야 할 것이다.

There is an increasing interest in the potential of isoflavone in reducing the risk of cardiovascular disease and cancer, however, although several effects of isoflavone as a component of soy protein are well established, the hypolipidemic and antioxidant effects of purified isoflavone are still controversial. This study was to investigate the effects of isoflavone on serum lipid profiles and antioxidant status in rats. 7-week old male Sprague Dawley rats were fed one of the following diets for 8 weeks: basal diet (B), basal+0.3% isoflavone (BI), basal+0.5% cholesterol (BC), or basal+0.3% isoflavone +0.5% cholesterol (BIC). Two-way ANOVA was used to test the effects of dietary isoflavone and cholesterol supplementation and their interaction on variables. Serum lipid profiles and total antioxidant status (TAS) were examined spectrophotometrically. Degree of serum lipid peroxidation was measured by malondialdehyde (MDA) assay. The activities of serum antioxidant enzymes (GSH-Px, total-SOD) was determined. Levels of serum total cholesterol, VLDL+LDL-cholesterol and Atherogenic index were significantly lower in BI than those levels in group B (p=0.0002, p<0.0001, and p=0.0042, respectively). Serum total antioxidant status (TAS) levels were significantly higher, in both isoflavone supplemented groups (BI, BIC) compared to those levels in each control group (B, BC) (p<0.0001). Activity of total-SOD was significantly higher in BI compared to the activities in group B (p=0.0317). There was no interaction between isoflavone and cholesterol supplementation. In conclusion, isoflavone supplementation showed positive effects on the serum lipid profiles and total antioxidant activities in both conditions, either when fed a diet with or without cholesterol. These effects of isoflavone were independent of cholesterol supplementation.

키워드

참고문헌

  1. Anderson, J. W., V. A. Drwadkar, and R. Susan. 1998. Selective effects of different antioxidants on oxidantion of lipoproteins from rats. Proceedings of the Society for Experimental Biology and Medicine. 218.
  2. Anderson, J. W., B. M. Johnstone, and M. E. Cook-Newell. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333, 276-282. https://doi.org/10.1056/NEJM199508033330502
  3. Anthony, M. S. 1995. Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. 1995. J. Nutr. 125, 803.
  4. Atteritano, M., H. Marini, L. Minutoli, F. Polito, A. Bitto, D. Altavilla, S. Mazzaferro, R. D’Anna, M. L. Cannata, and A. Gaudio. 2007.Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, post-menopausal women: a two-year randomized, doubleblind, placebo-controlled study. J. Clin. Endocrinol. Metabol. 92, 3068-3075. https://doi.org/10.1210/jc.2006-2295
  5. Bakhit, R. M., B. P. Klein, and D. Essex-Sorlie. 1994. Intake of 25g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J. Nutr. 124, 213-222.
  6. Bitto, A., D. Altavilla, A. Bonaiuto, F. Polito, L. Minutoli, L. Stefano, D. G. Salvatore, V. Arcoraci, and F. Squadrito. 2009. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J. Endocrinol. 200, 367-376.
  7. Buckingham, K. W. 1985. Effect of dietary polyunsaturated/saturated fatty acid ratio and dietary vitamin E on lipid peroxidation in the rat. J. Nutr. 115, 1425-1435.
  8. Cavallini, D. C. U., D. S. P. Abdalla, R. C. Vendramini, R. Bedani, L. Q. Bomdespacho, N. D. Pauly-Silveira, G. F. Valdez, and E. A. Rossi. 2009. Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study. Lipids Health Disease 8, 40-50. https://doi.org/10.1186/1476-511X-8-40
  9. Chan, S. G., S. C. Ho, N. Kreiger, G. Darlington, K. F. So, and P. Y. Y. Chong. 2007. Dietary sources and determinants of soy isoflavone intake among midlife Chinese women in Hong Kong. J. Nutr. 137, 2451-2455.
  10. Chen, H. W., C. L. Kuo, C. S. Huang, S. J. Kuo, and C. S. Liu. 2008. Oxidized lowdensity lipoproteins, autoantibodies against oxidized lowdensity lipoproteins and carotid intima media thickness in a clinically healthy population. Cardiol. 110, 252-259. https://doi.org/10.1159/000112409
  11. Choi, M. J. and H. J. Jo. 2005. Effects of isoflavones supplemented diet on lipid concentrarions and hepatic LDL receptor mRNA level in growing female rats. Korean Nutr. Soc. 38, 89-95.
  12. Choi, Y., S. Yoon, M. J. Lee, S. K. Lee, and B. S. Lee. 2001. Dose response relationship of isoflavone supplementation on plasma lipid profiles and total antioxidant status in perimenopausal and postmenopausal women. Korean Nutr. Soc. 34, 322-329.
  13. Deagen, J. T., J. Butle, M. Beilstein, and P. D. Whagner. 1987. Effects of dietary selenite, selenocysteine and selenomethione o-selenocysteine lyase and glutathione peroxidase activites on selenium levels in rat tissues. J. Nutr. 117, 91-98.
  14. Food and Drug Administration. 1999. Food labeling, health claims, soy protein, and coronary heart disease. Fed. Reg. 57, 699-733.
  15. Fotsis, M., H. Adlercreutz, T. Hase, R. Montesano, and L. Schweigerer. 1995. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 125, 790-797.
  16. Franke, A. A., B. M. Halm, K. Kakazu, X. Li, and L. J. Custer. 2009. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Analysis 1, 14-21. https://doi.org/10.1002/dta.12
  17. Gardner, C. D., L. M. Chatterjee, and A. A. Franke. 2009. Effects of isoflavone supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. J. Nutr. Biochem. 20, 227-234. https://doi.org/10.1016/j.jnutbio.2008.02.008
  18. Giovannetti, P. M., K. K. Carroll, and B. M. Wolfe. 1986. Constancy of fasting serum cholesterol of healthy young women upon substitution of isolated soy protein for meat and dairy protein in medium and low fat diets. Nutr. Res. 6, 609-618. https://doi.org/10.1016/S0271-5317(86)80002-1
  19. Haglund, O., R. Loustarinen, R. Wallin, I. Wibell, and T. Saldeen. 1991. The effect of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin. Eur. J. Nutr. 121, 165-172.
  20. Jenkins, D. J., C. W. Kendall, C. J. Jackson, P. W. Connelly, T. Parker, D. Faulkner, E. Vidgen, S. C. Cunnane, L. A. Leiter, and R. G. Josse. 2002. Effects of high- and low- isoflavone soyfoods on blood lipids, oxidized LDL, homocystein, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr. 76, 365-372.
  21. Kim, S. Y., E. J. Chung, J. Kim, J. Ahn, J. H. Park, S. Yoon, Y. C. Lee-Kim. 2000. Age-related difference in antioxidant effects of soybean protein concentrate in female rats. FASEB J. 364, 4.
  22. Lee, Y. S., S. Y. Jang, and K. O. Kim. 2005. Effects of soy isoflavone intake on Nitrite content and antioxidant enzyme activites in male rats fed high-fat diet. Korean Nutr. Soc. 38, 89-95.
  23. Lee, Y. S., C. Xiaowei, and J. Anderson. 2001. Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteoblast-like cells. Nutr. Res. 21, 1287-1298. https://doi.org/10.1016/S0271-5317(01)00340-2
  24. Lovati, M. R., C. Manzoni, and A. Canavesi. 1987. Soybean proteindiet increases low density liporotein receptor activity in mononuclear cells from hypercholesterolemic patients. J. Clin. Invest 80, 1498-1502. https://doi.org/10.1172/JCI113232
  25. Madani, S., J. M. Frenoux, J. Prost, and J. Bellecille. 2004. Changes in serum lipoprotein lipids and their fatty acid compositions and lipid peroxidation in growing rats fed soybean protein versus casein with or without cholesterol. Nutr. 20, 554-563. https://doi.org/10.1016/j.nut.2004.03.010
  26. Marguerite, A. K., R. L. Nahin, M. J. Messina, J. I .Rader, L. U. Thompson, T. M. Badger, J. T. Dwyer, Y. S. Kim, C. H. Pontzer, P. E. Starke-Reed, and C. M. Weave. 2010. Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J. Nutr. 140, 1192S-1204S. https://doi.org/10.3945/jn.110.121830
  27. Marklund, S. and G. Marklund. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474. https://doi.org/10.1111/j.1432-1033.1974.tb03714.x
  28. Messina, M., C. Nagata, and A. H. Wu. 2006. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 55, 1-12. https://doi.org/10.1207/s15327914nc5501_1
  29. Miller, N. J., C. Castellucio, L. Tijburg, and C. Rice-Evans. 1996. The antioxidant properties of theaflavins and their gallate esters-radical scavengers or metal chelators. FEBS Letters 392, 40-44. https://doi.org/10.1016/0014-5793(96)00780-6
  30. Mohamedain, M. 2000. Cholesterol-rich diets have different effects on lipid peroxidation, cholesterol oxides, and antioxidant enzymes in rats. J. Nutr. Biochem. 11, 293-302. https://doi.org/10.1016/S0955-2863(00)00083-8
  31. Owen, A. and P. Baghurst. 2000. The effect of isoflavone supplementation on serum lipids in postmenopausal women. Clin. Esp. Pharmacol. Physiol. 27, A32.
  32. Paglia, D. E. and W. N. Valentin.1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidation. J. Lab. Clin. Med. 70, 158-169.
  33. Patel, R. P., B. J. Boersma, J. H. Crawford, N. Hogg, M. Kirk, B. Kalyanaraman, D. A. Parks, S. Barnes, and U. Darley. 2001. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic. Biol. Med. 31, 1570-8115. https://doi.org/10.1016/S0891-5849(01)00737-7
  34. Patsch, W. D. 2001. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) Study. Circulation 104, 1108-1113. https://doi.org/10.1161/hc3501.095214
  35. Potter, S. M. 1996. Soy protein and serum lipids. Curr. Opin. Lipidol. 7, 260-264. https://doi.org/10.1097/00041433-199608000-00013
  36. Rodrdanz, E., S. Ohler, Q. H. Tran-Thi, and R. Kahl. 2002. The phytoestrogen daidzein affects the antioxidant enzyme system of rat hepatoma H4IIE cells. J. Nutr. 132, 370-375.
  37. Sacks, F. M., J. L. Breslow, and P. G. Wood. 1983. Lack of an effect of diary protein (casein) and soy protein on plasma cholesterol of strict vegetarians: an experiment and a critical review. J. Lipid Res. 24, 1012-1020.
  38. Sacks, F. M., A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, and M. Winston. 2006. Soy protein, isoflavones, and cardiovascular health. An American Heart Association Science Advisory for Professionals from the Nutrition Committee. Circulation 113, 1034-1044. https://doi.org/10.1161/CIRCULATIONAHA.106.171052
  39. Sheri, Z. C., C. L. Keen, and L. S. Hurley. 1983. Superoxide dismutase activity and lipid peroxidation in the rat: developmental correlations affected by manganese deficiency. J. Nutr. 113, 2498-2504.
  40. Susan, M. Potter. 2000. Soy-new health benefits associated with an ancient food. Nutrition Today 35, 53-60. https://doi.org/10.1097/00017285-200003000-00004
  41. Sirtori, C. R. and M. R. Lovati. 1995. Soy and cholesterol reduction: clinical experience. J. Nutr. 125, 598-605.
  42. Torres, N., I. Torre-Villalvazo, and A. R. Tovar. 2006. Regulation of lipid metabolism by soy protein and its mplication in diseases mediated by lipid disorders. J. Nutr. Biochem. 17, 365-373. https://doi.org/10.1016/j.jnutbio.2005.11.005
  43. Vertuani, S., A. Angusti, and S. Manfredini. 2004. The antioxidants and pro-antioxidants network: an overview. Curr. Pharmaceutical Design 10, 1677-1694. https://doi.org/10.2174/1381612043384655
  44. Wilcox, J. N. and B. F. Blumental. 1995. Thrombotic mechanism in atherosclerosis: potential impact of soy proteins. J. Nutr. 125, 631-638.
  45. Wiseman, H., J. D. O’Reilly, H. Adlercreutz, A. I. Mallet, E. A. Bowey, J. R. Rowland, and T. Sanders.2000. Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72, 395-400.
  46. Xiao, C. W. 2008. Health effects of soy protein and isoflavones in Humans. J. Nutr. 138, 1244-1249.
  47. Yagi, K. 1976. A simple flourometric assay for lipoperoxide in blood plasma. Biochem. Med. 15, 212-216. https://doi.org/10.1016/0006-2944(76)90049-1

피인용 문헌

  1. Effective Anti-aging Strategies in an Era of Super-aging vol.20, pp.3, 2014, https://doi.org/10.6118/jmm.2014.20.3.85